Goldman Sachs Group Inc Alpha Tau Medical Ltd. Transaction History
Goldman Sachs Group Inc
- $780 Billion
- Q3 2025
A detailed history of Goldman Sachs Group Inc transactions in Alpha Tau Medical Ltd. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 12,315 shares of DRTS stock, worth $45,688. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,315Holding current value
$45,688% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding DRTS
# of Institutions
37Shares Held
2.25MCall Options Held
0Put Options Held
0-
High Tower Advisors, LLC Chicago, IL687KShares$2.55 Million0.0% of portfolio
-
Hoyle Cohen, LLC269KShares$998,3160.05% of portfolio
-
Levin Capital Strategies, L.P. New York, NY205KShares$759,4880.09% of portfolio
-
Kovitz Investment Group Partners, LLC203KShares$753,9870.0% of portfolio
-
Mariner, LLC Overland Park, KS123KShares$457,2570.0% of portfolio
About Alpha Tau Medical Ltd.
- Ticker DRTS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,011,296
- Market Cap $256M
- Description
- Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast canc...